TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.
Wong N, Yeo W, Wong WL, Wong NL, Chan KY, Mo FK, Koh J, Chan SL, Chan AT, Lai PB, Ching AK, Tong JH, Ng HK, Johnson PJ, To KF.
Wong N, et al. Among authors: chan ky, chan at, chan sl.
Int J Cancer. 2009 Feb 1;124(3):644-52. doi: 10.1002/ijc.23968.
Int J Cancer. 2009.
PMID: 19003983
Clinical Trial.